Digital download
Access the files immediately after checkout.

Access the files immediately after checkout.
Edit, adapt and present the analysis in familiar formats.
Map Stars, Cash Cows, Question Marks and Dogs.
Compare where to invest, maintain or rationalize.
Turn portfolio position into clear priorities.
Quick glance: RELX Group’s BCG Matrix snapshot shows where its businesses likely sit—market leaders, cash generators, or areas needing a rethink. Want the full picture? Purchase the complete BCG Matrix for quadrant-by-quadrant placement, data-backed recommendations and a ready-to-use Word report plus an Excel summary to guide investment and product decisions. Get instant strategic clarity and save hours of work—buy now.
Legacy print‑only titles suffer declining demand, rising unit costs and limited differentiation—print now represents under 5% of RELX segment revenues in 2024, making them cash neutral at best and often a distraction from higher-margin digital products. With digital alternatives delivering scale, faster analytics and better margins, turnaround is difficult and costly. Prune aggressively and redeploy capital and talent into digital platforms and data services to maximize ROI.
CD/DVD reference products are an obsolete form factor with near-zero growth and minimal maintenance overhead; customers now expect cloud and API delivery instead. Revenue only trickles and primarily ties up support resources, making it a low-return Dog in RELX’s BCG matrix. Recommend sunsetting with clear migration paths to hosted APIs and data subscriptions to preserve client continuity and reduce support cost.
Small regional trade shows are Dogs: fragmented local audiences and sponsor fatigue lower ROI, while local competition and constrained corporate travel budgets cap growth. Operational complexity and overheads frequently outweigh modest returns, squeezing margins and allocation efficiency. Consolidate or divest these events to redeploy resources into scalable, high-growth franchises.
On‑Prem Legal Software Modules sit in Dogs: customers are migrating to SaaS, upgrade cycles stall, support costs linger and margins compress; little competitive edge remains. IDC 2024 notes cloud deployments exceeded on‑prem in many enterprise software segments, forcing RELX to migrate or retire modules to cut the tail.
Low‑margin ad directories face platform competition and commoditization, eroding pricing power and user differentiation. Monetization is weak and volatile, with classifieds often showing single‑digit EBITDA contribution and pronounced quarterly revenue swings in 2024. Strategic value to RELX is limited; exit or fold listings into higher‑value information services and analytics.
Legacy print under 5% of RELX segment revenue in 2024, CD/DVD revenues near zero, small regional shows and on‑prem modules show declining demand and thin margins; ad directories deliver single‑digit EBITDA in 2024. These Dogs tie up support/OPEX and cap investment in digital growth. Sunset, consolidate or migrate to SaaS/APIs and reallocate capital to high‑growth data platforms.
| Category | 2024 Rev share | 2024 EBITDA | Action |
|---|---|---|---|
| <5% | Neutral/low | Prune/migrate | |
| CD/DVD | ~0% | Negligible | Retire |
| Regional shows | Low | Negative/low | Consolidate/divest |
| On‑prem modules | Declining | Compressed | Migrate to SaaS |
| Ad directories | Low | Single‑digit EBITDA | Exit/integrate |
GenAI Research Assistants are a rapidly growing but still contested question mark for RELX: market demand is high yet share remains fluid, and the opportunity scales only if tightly integrated with RELX’s vetted content and citation networks.
Realizing value requires heavy investment in proprietary models, robust guardrails, and UX tailored to legal, scientific, and regulatory workflows. Commit and differentiate on trust and explainability—or pivot fast if adoption and ROI don’t materialize.
AI‑native legal drafting is a Question Mark: law firms show strong demand but the space is crowded with startups and Big Tech entrants. RELX can leverage superior data quality and unmatched precedent coverage from LexisNexis to differentiate. However, cost to win is significant — GPU compute, human evaluation, and enterprise integrations drive CAPEX and operating expense. Move fast to scale in core practices or retrench if adoption and commercial traction lag.
Regulatory tailwinds are strong—EU CSRD expanded reporting to about 50,000 companies from 2024—yet standards and metrics are still settling and competition is noisy. RELX can differentiate by combining entity graphs with its news and legal datasets to detect supplier risk and litigation signals. Revenue is early and leadership in this niche remains uncertain, so invest selectively where compliance complexity is highest and buyer budgets are established.
Question Marks: Healthcare Real‑World Evidence sits in a high-growth but uncertain BCG quadrant as pharma and payers increasingly demand outcomes data, while data rights and interoperability remain fragmented; 2024 industry reports show RWE adoption accelerating but commercial models still immature. Upfront costs and consortium partnerships are capital‑intensive; RELX can scale by testing niches with clear ROI and improving coverage and curation.
SMB risk and credit in emerging markets offer a large addressable opportunity—SMEs make up about 90% of businesses and 50% of employment globally, while the IFC estimated a developing-country SME financing gap of roughly 5.2 trillion USD. Current RELX penetration is low; data scarcity and localization add friction, but assembling reliable localized signals could create a durable analytics moat. Pilot in targeted countries before scaling.
RELX Question Marks (GenAI, AI legal drafting, CSRD/regulatory analytics, RWE, emerging‑market SMB risk) show high market growth but uncertain share; 2024 signals: EU CSRD ~50,000 firms, IFC SME finance gap ~5.2T, RWE adoption rising. Winning needs heavy capex, data rights work, and narrow go‑to‑market bets; pivot if ROI lags.
| Theme | 2024 signal | Implication |
|---|---|---|
| GenAI | fast demand | large invest |
| CSRD | 50,000 firms | compliance sell‑in |
| SME | 5.2T gap | pilot markets |